Who’s paving the way for LGBTQ+ lead­ers in bio­phar­ma? Nom­i­nate them for End­points’ an­nu­al re­port

Last year, I sec­ond-guessed whether we should con­tin­ue run­ning an an­nu­al spe­cial re­port high­light­ing LGBTQ+ lead­ers in the bio­phar­ma in­dus­try.

We al­ready had Women in Bio­phar­ma and 20 un­der 40 re­ports, so why add a third? But then, on the same day we pub­lished the 2023 edi­tion, the Hu­man Rights Cam­paign is­sued its first-ever “state of emer­gency” for LGBTQ+ Amer­i­cans.

The bio­phar­ma in­dus­try, you might ask, prob­a­bly has noth­ing to do with the LGBTQ rights front. Right?

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER